Aveanna Healthcare (NASDAQ:AVAH) Earns "Hold (C)" Rating from Weiss Ratings

Key Points

• Aveanna Healthcare's stock received a "hold (c)" rating from Weiss Ratings while Barclays upgraded it to "overweight" with a price target increase from $5.50 to $9.50.
• The stock currently has an average rating of "Hold" and a consensus target price of $7.92, with three analysts giving it a "buy" rating.
• Aveanna Healthcare's shares reached $8.95, with a significant increase in trading volume compared to its average, and the stock has a 52-week high of $9.03.

Aveanna Healthcare (NASDAQ:AVAH - Get Free Report)'s stock had its "hold (c)" rating reissued by equities research analysts at Weiss Ratings in a report released on Wednesday,Weiss Ratings reports.

Other research analysts have also recently issued research reports about the company. Barclays raised Aveanna Healthcare from an "equal weight" rating to an "overweight" rating and boosted their price objective for the stock from $5.50 to $9.50 in a research report on Tuesday, August 19th. Jefferies Financial Group upgraded Aveanna Healthcare from a "hold" rating to a "buy" rating and dropped their target price for the company from $6.25 to $6.00 in a report on Monday, July 21st. Truist Financial lowered their target price on Aveanna Healthcare from $6.00 to $5.00 and set a "hold" rating for the company in a research note on Wednesday, July 16th. Wall Street Zen raised Aveanna Healthcare from a "buy" rating to a "strong-buy" rating in a report on Saturday, August 9th. Finally, Raymond James Financial raised Aveanna Healthcare from a "market perform" rating to an "outperform" rating and set a $9.00 target price on the stock in a report on Monday, August 11th. Three equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $7.92.

Aveanna Healthcare Stock Performance

Shares of AVAH traded up $0.42 during mid-day trading on Wednesday, reaching $8.95. 1,565,576 shares of the company were exchanged, compared to its average volume of 687,675. The business has a 50 day simple moving average of $7.45 and a two-hundred day simple moving average of $5.78. Aveanna Healthcare has a 52 week low of $3.67 and a 52 week high of $9.03. The stock has a market capitalization of $1.87 billion, a PE ratio of 111.88 and a beta of 2.05.

Institutional Investors Weigh In On Aveanna Healthcare

A number of hedge funds have recently added to or reduced their stakes in the stock. Bank of America Corp DE raised its position in shares of Aveanna Healthcare by 43.4% in the 4th quarter. Bank of America Corp DE now owns 50,040 shares of the company's stock valued at $229,000 after acquiring an additional 15,140 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new position in Aveanna Healthcare in the fourth quarter valued at about $223,000. California State Teachers Retirement System grew its stake in Aveanna Healthcare by 1,099.2% in the fourth quarter. California State Teachers Retirement System now owns 45,413 shares of the company's stock valued at $208,000 after acquiring an additional 41,626 shares during the period. Rhumbline Advisers grew its stake in Aveanna Healthcare by 4.0% in the first quarter. Rhumbline Advisers now owns 75,581 shares of the company's stock valued at $410,000 after acquiring an additional 2,918 shares during the period. Finally, Teacher Retirement System of Texas grew its stake in Aveanna Healthcare by 50.9% in the first quarter. Teacher Retirement System of Texas now owns 49,881 shares of the company's stock valued at $270,000 after acquiring an additional 16,835 shares during the period. Institutional investors own 87.96% of the company's stock.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.